Safety and outcome of intravenous thrombolysis with rtPA in patients with atrial fibrillation
Background and purpose. Intravenous administration of recombinant tissue plasminogen activator (rtPA) is approved for the treatment of patients with acute ischemic stroke. It is still controversial if in patients with ischemic stroke due to atrial fibrillation this treatment has the same efficacy as...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Amaltea Medical Publishing House
2012-09-01
|
| Seri Bilgileri: | Romanian Journal of Neurology |
| Konular: | |
| Online Erişim: | https://rjn.com.ro/articles/2012.3/RJN_2012_3_Art-03.pdf |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|